These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16244774

  • 1. Coagulation and fibrinolysis in preeclampsia and neonates.
    Tanjung MT, Siddik HD, Hariman H, Koh SC.
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):467-73. PubMed ID: 16244774
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
    Koh SC, Anandakumar C, Montan S, Ratnam SS.
    Gynecol Obstet Invest; 1993 Oct; 35(4):214-21. PubMed ID: 8330765
    [Abstract] [Full Text] [Related]

  • 3. Coagulation activation, fibrinolysis and inhibitors in neonates.
    Koh SC, Cheong YC, Arulkumaran S, Ratnam SS.
    Ann Acad Med Singap; 1997 Nov; 26(6):767-71. PubMed ID: 9522977
    [Abstract] [Full Text] [Related]

  • 4. Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy.
    Yin KH, Koh SC, Malcus P, SvenMontan S, Biswas A, Arulkumaran S, Ratnam SS.
    J Obstet Gynaecol Res; 1998 Jun; 24(3):231-8. PubMed ID: 9714995
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A, Kobayashi T, Terao T.
    Gynecol Obstet Invest; 1996 Jun; 42(2):95-101. PubMed ID: 8878712
    [Abstract] [Full Text] [Related]

  • 6. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation.
    Schjetlein R, Haugen G, Wisløff F.
    Acta Obstet Gynecol Scand; 1997 Jul; 76(6):541-6. PubMed ID: 9246959
    [Abstract] [Full Text] [Related]

  • 7. Maternal and cord blood hemostasis at delivery.
    Schneider DM, von Tempelhoff GF, Herrle B, Heilmann L.
    J Perinat Med; 1997 Jul; 25(1):55-61. PubMed ID: 9085204
    [Abstract] [Full Text] [Related]

  • 8. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
    Estellés A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR.
    Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307
    [Abstract] [Full Text] [Related]

  • 9. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P, Kapiotis S, Pärtan C, Schneider B, Wenzel R, Gaiger A, Speiser W.
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [Abstract] [Full Text] [Related]

  • 10. The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns.
    Zanardo V, Savio V, Sabrina G, Franzoi M, Zerbinati P, Fadin M, Tognin G, Tormene D, Pagnan A, Simioni P.
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):177-81. PubMed ID: 15795535
    [Abstract] [Full Text] [Related]

  • 11. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
    Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patricio B, Quintanilha A, Santos-Silva A.
    Thromb Res; 2008 Apr; 123(2):219-24. PubMed ID: 18384840
    [Abstract] [Full Text] [Related]

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 13. Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia.
    Roes EM, Sweep CG, Thomas CM, Zusterzeel PL, Geurts-Moespot A, Peters WH, Steegers EA.
    Am J Obstet Gynecol; 2002 Oct 22; 187(4):1019-25. PubMed ID: 12388999
    [Abstract] [Full Text] [Related]

  • 14. [Endothelial damage and blood coagulation activation in preeclampsia].
    Stella A, Babbo GL, Grella PV.
    Minerva Ginecol; 1998 Nov 22; 50(11):463-8. PubMed ID: 9882986
    [Abstract] [Full Text] [Related]

  • 15. Effects of labor and delivery on fibrinolysis.
    Bremer HA, Brommer EJ, Wallenburg HC.
    Eur J Obstet Gynecol Reprod Biol; 1994 Jun 30; 55(3):163-8. PubMed ID: 7958159
    [Abstract] [Full Text] [Related]

  • 16. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L.
    Am J Perinatol; 1998 Feb 30; 15(2):81-5. PubMed ID: 9514130
    [Abstract] [Full Text] [Related]

  • 17. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
    DeSouza CA, Jones PP, Seals DR.
    Arterioscler Thromb Vasc Biol; 1998 Mar 30; 18(3):362-8. PubMed ID: 9514404
    [Abstract] [Full Text] [Related]

  • 18. Effects of preeclampsia and eclampsia on cord blood coagulation tests.
    Djelmis J, Buković D, Ivanisević M, Kovacević V, Pfeifer D.
    Coll Antropol; 1998 Jun 30; 22(1):113-7. PubMed ID: 10097426
    [Abstract] [Full Text] [Related]

  • 19. Coagulation index to distinguish severe preeclampsia from normal pregnancy.
    Kobayashi T, Sumimoto K, Tokunaga N, Sugimura M, Nishiguchi T, Kanayama N, Terao T.
    Semin Thromb Hemost; 2002 Dec 30; 28(6):495-500. PubMed ID: 12536338
    [Abstract] [Full Text] [Related]

  • 20. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
    Bremme K, Blombäck M.
    Gynecol Obstet Invest; 1996 Dec 30; 41(1):20-6. PubMed ID: 8821879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.